Prognostic and predictive biomarker developments in multiple myeloma

CT Wallington-Beddoe, RL Mynott - Journal of hematology & oncology, 2021 - Springer
New approaches to stratify multiple myeloma patients based on prognosis and therapeutic
decision-making, or prediction, are needed since patients are currently managed in a similar …

IMWG consensus on risk stratification in multiple myeloma

WJ Chng, A Dispenzieri, CS Chim, R Fonseca… - Leukemia, 2014 - nature.com
Multiple myeloma is characterized by underlying clinical and biological heterogeneity, which
translates to variable response to treatment and outcome. With the recent increase in …

The genetic architecture of multiple myeloma

GJ Morgan, BA Walker, FE Davies - Nature Reviews Cancer, 2012 - nature.com
Based on the clinical features of myeloma and related malignancies of plasma cells, it has
been possible to generate a model system of myeloma progression from a normal plasma …

Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients

V Shah, AL Sherborne, BA Walker, DC Johnson… - Leukemia, 2018 - nature.com
Robust establishment of survival in multiple myeloma (MM) and its relationship to recurrent
genetic aberrations is required as outcomes are variable despite apparent similar staging …

A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial

KD Boyd, FM Ross, L Chiecchio, GP Dagrada, ZJ Konn… - Leukemia, 2012 - nature.com
The association of genetic lesions detected by fluorescence in situ hybridization (FISH) with
survival was analyzed in 1069 patients with newly presenting myeloma treated in the …

A gene expression signature for high-risk multiple myeloma

R Kuiper, A Broyl, Y de Knegt, MH Van Vliet… - Leukemia, 2012 - nature.com
There is a strong need to better predict the survival of patients with newly diagnosed multiple
myeloma (MM). As gene expression profiles (GEPs) reflect the biology of MM in individual …

Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t (4; 14) and t (11; 14) myeloma

BA Walker, CP Wardell, L Melchor… - Blood, The Journal …, 2012 - ashpublications.org
We have used whole exome sequencing to compare a group of presentation t (4; 14) with t
(11; 14) cases of myeloma to define the mutational landscape. Each case was characterized …

Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma

BA Walker, CP Wardell, L Chiecchio… - Blood, The Journal …, 2011 - ashpublications.org
We used genome-wide methylation microarrays to analyze differences in CpG methylation
patterns in cells relevant to the pathogenesis of myeloma plasma cells (B cells, normal …

Map** of Chromosome 1p Deletions in Myeloma Identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as Being Genes in Regions Associated with Adverse Survival

KD Boyd, FM Ross, BA Walker, CP Wardell… - Clinical cancer …, 2011 - AACR
Purpose: Regions on 1p with recurrent deletions in presenting myeloma patients were
examined with the purpose of defining the deletions and assessing their survival impact …

Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma

MF Kaiser, DC Johnson, P Wu… - Blood, The Journal …, 2013 - ashpublications.org
Outcome in multiple myeloma is highly variable and a better understanding of the factors
that influence disease biology is essential to understand and predict behavior in individual …